127 related articles for article (PubMed ID: 36683332)
1. Survival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients.
Erdoğu V; Çıtak N; Sezen CB; Kizir D; Tanrıkulu G; Doğru MV; Seyrek Y; Cansever L; Saydam Ö; Metin M
Asian Cardiovasc Thorac Ann; 2023 Mar; 31(3):238-243. PubMed ID: 36683332
[TBL] [Abstract][Full Text] [Related]
2. Survival Effect of Surgery in Patients with Stage IIIB/N2 Non-small Cell Lung Cancer: A Comparative Study with Definitive Chemoradiotherapy.
Erdoğu V; Aksoy Y; Sezen CB; Doğru MV; Yıldız N; Cansever L; Metin M
Thorac Res Pract; 2023 Nov; 25(1):35-41. PubMed ID: 38015162
[TBL] [Abstract][Full Text] [Related]
3. Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer.
Deng H; Liu J; Cai X; Chen J; Rocco G; Petersen RH; Brunelli A; Ng CSH; D'Amico TA; Liang W; He J
Ann Surg; 2022 Mar; 275(3):e600-e602. PubMed ID: 34596079
[TBL] [Abstract][Full Text] [Related]
4. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
[TBL] [Abstract][Full Text] [Related]
5. Importance of tumor size in resectable stage III-N2 non-small cell lung cancer.
Castro PP; de Perrot M; Chua YC; Bezjak A; Leighl N; Darling G; Pierre A; Yasufuku K; Cypel M; Waddell T; Donahoe L; Yeung J; Keshavjee S
J Thorac Cardiovasc Surg; 2022 Sep; 164(3):629-636. PubMed ID: 35331553
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
Garrido P; González-Larriba JL; Insa A; Provencio M; Torres A; Isla D; Sanchez JM; Cardenal F; Domine M; Barcelo JR; Tarrazona V; Varela A; Aguilo R; Astudillo J; Muguruza I; Artal A; Hernando-Trancho F; Massuti B; Sanchez-Ronco M; Rosell R
J Clin Oncol; 2007 Oct; 25(30):4736-42. PubMed ID: 17947721
[TBL] [Abstract][Full Text] [Related]
7. Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
Casiraghi M; Guarize J; Sandri A; Maisonneuve P; Brambilla D; Romano R; Galetta D; Petrella F; Gasparri R; Gridelli C; De Marinis F; Spaggiari L
Clin Lung Cancer; 2019 Mar; 20(2):97-106.e1. PubMed ID: 30446406
[TBL] [Abstract][Full Text] [Related]
8. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T
Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z
BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
11. Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
Collaud S; Provost B; Besse B; Fabre D; Le Chevalier T; Mercier O; Mussot S; Fadel E
J Surg Oncol; 2018 Jun; 117(7):1570-1574. PubMed ID: 29573419
[TBL] [Abstract][Full Text] [Related]
12. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
[TBL] [Abstract][Full Text] [Related]
13. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
[TBL] [Abstract][Full Text] [Related]
14. Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
Zheng D; Ye T; Hu H; Zhang Y; Sun Y; Xiang J; Chen H
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1814-1822.e4. PubMed ID: 29221745
[TBL] [Abstract][Full Text] [Related]
15. [Lung cancer: is surgery an option for persisting N2 after induction therapy?].
Haager B; Osei-Agyemang T; Passlick B; Wiesemann S
Zentralbl Chir; 2015 Feb; 140(1):99-103. PubMed ID: 25076164
[TBL] [Abstract][Full Text] [Related]
16. Extended surgical resection in stage III non-small cell lung cancer.
Hillinger S; Weder W
Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
[TBL] [Abstract][Full Text] [Related]
17. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
18. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B
Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
